Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4I991
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 124 | 128 | PF00656 | 0.632 |
CLV_C14_Caspase3-7 | 137 | 141 | PF00656 | 0.516 |
CLV_C14_Caspase3-7 | 200 | 204 | PF00656 | 0.733 |
CLV_C14_Caspase3-7 | 327 | 331 | PF00656 | 0.574 |
CLV_C14_Caspase3-7 | 65 | 69 | PF00656 | 0.772 |
CLV_NRD_NRD_1 | 129 | 131 | PF00675 | 0.722 |
CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.675 |
CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.722 |
CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.675 |
CLV_PCSK_SKI1_1 | 282 | 286 | PF00082 | 0.579 |
DEG_APCC_DBOX_1 | 281 | 289 | PF00400 | 0.569 |
DOC_AGCK_PIF_1 | 305 | 310 | PF00069 | 0.592 |
DOC_ANK_TNKS_1 | 70 | 77 | PF00023 | 0.718 |
DOC_CKS1_1 | 165 | 170 | PF01111 | 0.556 |
DOC_USP7_MATH_1 | 315 | 319 | PF00917 | 0.687 |
DOC_USP7_MATH_1 | 348 | 352 | PF00917 | 0.731 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.745 |
DOC_USP7_MATH_1 | 43 | 47 | PF00917 | 0.736 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.613 |
DOC_WW_Pin1_4 | 146 | 151 | PF00397 | 0.801 |
DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.566 |
LIG_14-3-3_CanoR_1 | 14 | 19 | PF00244 | 0.523 |
LIG_14-3-3_CanoR_1 | 31 | 37 | PF00244 | 0.538 |
LIG_14-3-3_CanoR_1 | 77 | 82 | PF00244 | 0.744 |
LIG_APCC_ABBAyCdc20_2 | 301 | 307 | PF00400 | 0.606 |
LIG_BIR_III_4 | 247 | 251 | PF00653 | 0.636 |
LIG_BIR_III_4 | 330 | 334 | PF00653 | 0.539 |
LIG_BRCT_BRCA1_1 | 140 | 144 | PF00533 | 0.722 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.596 |
LIG_FHA_1 | 348 | 354 | PF00498 | 0.675 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.710 |
LIG_FHA_2 | 151 | 157 | PF00498 | 0.674 |
LIG_FHA_2 | 195 | 201 | PF00498 | 0.730 |
LIG_FHA_2 | 287 | 293 | PF00498 | 0.542 |
LIG_LIR_Gen_1 | 139 | 150 | PF02991 | 0.634 |
LIG_LIR_Gen_1 | 307 | 316 | PF02991 | 0.623 |
LIG_LIR_Gen_1 | 95 | 105 | PF02991 | 0.582 |
LIG_LIR_Nem_3 | 139 | 145 | PF02991 | 0.635 |
LIG_LIR_Nem_3 | 307 | 311 | PF02991 | 0.639 |
LIG_LIR_Nem_3 | 95 | 101 | PF02991 | 0.574 |
LIG_NRBOX | 177 | 183 | PF00104 | 0.640 |
LIG_REV1ctd_RIR_1 | 308 | 317 | PF16727 | 0.664 |
LIG_SH2_CRK | 142 | 146 | PF00017 | 0.573 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.573 |
LIG_SH2_STAT5 | 142 | 145 | PF00017 | 0.624 |
LIG_SH2_STAT5 | 308 | 311 | PF00017 | 0.681 |
LIG_SH3_3 | 162 | 168 | PF00018 | 0.580 |
LIG_TRAF2_1 | 197 | 200 | PF00917 | 0.728 |
LIG_TRAF2_1 | 93 | 96 | PF00917 | 0.687 |
MOD_CK1_1 | 164 | 170 | PF00069 | 0.752 |
MOD_CK1_1 | 26 | 32 | PF00069 | 0.631 |
MOD_CK1_1 | 268 | 274 | PF00069 | 0.693 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.699 |
MOD_CK1_1 | 52 | 58 | PF00069 | 0.751 |
MOD_CK2_1 | 194 | 200 | PF00069 | 0.724 |
MOD_CK2_1 | 268 | 274 | PF00069 | 0.693 |
MOD_CK2_1 | 286 | 292 | PF00069 | 0.440 |
MOD_CK2_1 | 315 | 321 | PF00069 | 0.665 |
MOD_CK2_1 | 348 | 354 | PF00069 | 0.668 |
MOD_CK2_1 | 43 | 49 | PF00069 | 0.782 |
MOD_CK2_1 | 90 | 96 | PF00069 | 0.694 |
MOD_Cter_Amidation | 127 | 130 | PF01082 | 0.595 |
MOD_GlcNHglycan | 107 | 111 | PF01048 | 0.690 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.727 |
MOD_GlcNHglycan | 169 | 172 | PF01048 | 0.600 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.701 |
MOD_GlcNHglycan | 317 | 320 | PF01048 | 0.597 |
MOD_GlcNHglycan | 327 | 330 | PF01048 | 0.548 |
MOD_GlcNHglycan | 335 | 338 | PF01048 | 0.676 |
MOD_GlcNHglycan | 350 | 353 | PF01048 | 0.520 |
MOD_GlcNHglycan | 374 | 377 | PF01048 | 0.670 |
MOD_GlcNHglycan | 45 | 48 | PF01048 | 0.545 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.585 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.697 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.592 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.621 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.752 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.747 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.650 |
MOD_N-GLC_1 | 190 | 195 | PF02516 | 0.690 |
MOD_N-GLC_1 | 219 | 224 | PF02516 | 0.684 |
MOD_N-GLC_1 | 286 | 291 | PF02516 | 0.553 |
MOD_N-GLC_1 | 85 | 90 | PF02516 | 0.743 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.757 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.734 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.619 |
MOD_NEK2_1 | 372 | 377 | PF00069 | 0.705 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.607 |
MOD_NEK2_2 | 306 | 311 | PF00069 | 0.618 |
MOD_PIKK_1 | 184 | 190 | PF00454 | 0.569 |
MOD_PK_1 | 255 | 261 | PF00069 | 0.703 |
MOD_PKA_2 | 26 | 32 | PF00069 | 0.638 |
MOD_PKA_2 | 76 | 82 | PF00069 | 0.745 |
MOD_Plk_1 | 150 | 156 | PF00069 | 0.603 |
MOD_Plk_1 | 265 | 271 | PF00069 | 0.723 |
MOD_Plk_1 | 306 | 312 | PF00069 | 0.677 |
MOD_Plk_2-3 | 265 | 271 | PF00069 | 0.723 |
MOD_Plk_2-3 | 364 | 370 | PF00069 | 0.716 |
MOD_Plk_4 | 140 | 146 | PF00069 | 0.688 |
MOD_Plk_4 | 268 | 274 | PF00069 | 0.693 |
MOD_Plk_4 | 306 | 312 | PF00069 | 0.679 |
MOD_ProDKin_1 | 146 | 152 | PF00069 | 0.801 |
MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.561 |
MOD_SUMO_rev_2 | 114 | 122 | PF00179 | 0.624 |
MOD_SUMO_rev_2 | 247 | 256 | PF00179 | 0.710 |
TRG_ENDOCYTIC_2 | 142 | 145 | PF00928 | 0.574 |
TRG_ENDOCYTIC_2 | 308 | 311 | PF00928 | 0.634 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S5H7U9 | Leishmania donovani | 100% | 100% |
A4HLT2 | Leishmania braziliensis | 57% | 100% |
E9B458 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q4Q3W7 | Leishmania major | 83% | 100% |